Dolby Laboratories, Inc.
DLB
$75.75
-$0.04-0.05%
NYSE
| 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | 12/29/2023 | |
|---|---|---|---|---|---|
| Net Income | 67.82M | 58.57M | 38.44M | 97.83M | 66.98M |
| Total Depreciation and Amortization | 25.20M | 24.38M | 21.21M | 20.78M | 20.96M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 26.68M | 21.52M | 13.88M | 26.95M | 22.36M |
| Change in Net Operating Assets | -12.92M | 11.70M | -52.27M | 35.86M | -101.89M |
| Cash from Operations | 106.78M | 116.17M | 21.26M | 181.41M | 8.41M |
| Capital Expenditure | -6.78M | -7.38M | -7.61M | -8.92M | -6.10M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1.36M | -487.88M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 233.95M | -131.00K | -8.96M | 6.73M |
| Cash from Investing | -8.14M | -261.31M | -7.74M | -17.87M | 633.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 22.16M | 716.00K | 10.14M | 11.04M | 19.02M |
| Repurchase of Common Stock | -47.44M | -21.65M | -36.37M | -26.49M | -114.56M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -31.55M | -28.61M | -28.70M | -28.72M | -28.55M |
| Other Financing Activities | -740.00K | -10.58M | -3.46M | 0.00 | -1.05M |
| Cash from Financing | -57.57M | -60.12M | -58.40M | -44.16M | -125.14M |
| Foreign Exchange rate Adjustments | -7.16M | 4.38M | -857.00K | -3.68M | 6.79M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 33.91M | -200.87M | -45.73M | 115.70M | -109.31M |